ASCO 2018 highlights: metastatic breast cancer

This article reviews the clinically most relevant presentations at the American Society of Clinical Oncology (ASCO) annual meeting 2018 on the topic of metastatic breast cancer. In the randomized placebo-controlled phase 3 trial MONALEESA-3, testing ribociclib vs. placebo in combination with fulvest...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinnerthaler, Gabriel, Gampenrieder, Simon Peter, Greil, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2018
Materias:
Short Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280779/
https://www.ncbi.nlm.nih.gov/pubmed/30595753
http://dx.doi.org/10.1007/s12254-018-0450-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280779/
https://www.ncbi.nlm.nih.gov/pubmed/30595753
http://dx.doi.org/10.1007/s12254-018-0450-9

Ejemplares similares